Streetbeat News

Assets

GNTY

Guaranty Bancshares has announced the appointment of Shalene Jacobson as CFO, succeeding Clifton 'Cappy' Payne, effective from December 29, 2023. Payne will also retire from the Board of Directors on December 31, 2023, and from the company on March 31, 2024, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:14 pm

CTRM

Castor Maritime Inc. (NASDAQ:CTRM) has announced the sale of two of its Panamax bulk carrier vessels, the M/V Magic Sun and M/V Magic Phoenix, for a total of $20.55 million. The company expects to record a net gain of $1.0 million from the sale of the M/V Magic Sun and a net loss of $2.6 million from the sale of the M/V Magic Phoenix in Q4 2023.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:13 pm

EDBL

Edible Garden has received a USDA grant to cover the costs of organic certification for its Belvidere, New Jersey facility. The amount of the grant has not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:01 pm

DEA

Easterly Government Properties has acquired a 35,005 square foot U.S. District Courthouse in Newport News, Virginia. The financial details of the transaction were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:01 pm

EIS

GLD

The ongoing conflict between Israel and Hamas has led to a stabilization of the Israeli shekel after 10 consecutive sessions of losses, and a 14% drop in the iShares MSCI Israel ETF (EIS) since the conflict began. The SPDR Gold Trust (GLD) held steady at $1,980 per ounce despite another round of selloffs in U.S. Treasuries.

Portfolio Pulse from Piero Cingari

October 23, 2023 | 12:57 pm

IPA

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) has provided an update on its growth strategy, emphasizing its commitment to expanding its contract research organization (CRO) capabilities and leveraging technology for innovation. The company's subsidiary, BioStrand, is playing a key role in this strategy. IPA has also reported a 21.3% increase in revenue for the first quarter of fiscal year 2024, and a 44.0% growth in its protein manufacturing facility. Despite a recent drop in stock price, IPA remains optimistic about its future growth.

Portfolio Pulse from Happy Mohamed

October 23, 2023 | 12:18 pm

NAMS

NewAmsterdam Pharma (NASDAQ:NAMS) has appointed Ian Somaiya as its new Chief Financial Officer. Somaiya has over 25 years of experience in the biopharmaceutical industry and has held senior leadership roles at Elucida Oncology and TCR2 Therapeutics. He will provide strategic financial leadership as NewAmsterdam continues to invest in obicetrapib's clinical development.

Portfolio Pulse from Happy Mohamed

October 23, 2023 | 12:11 pm

ICAD

iCAD, Inc. has announced the sale of its Xoft Brachytherapy business line to Elekta for approximately $5.5 million.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 12:09 pm

ALGS

Aligos Therapeutics, Inc. (NASDAQ:ALGS) has announced a private placement financing expected to generate $92 million in gross proceeds. The funds will be used to advance its portfolio of drug candidates, including its Phase 2a NASH, ALG-055009 study, and its CAM-E candidate, ALG-000184. The financing is expected to extend the company's cash runway through the end of 2025.

Portfolio Pulse from Happy Mohamed

October 23, 2023 | 12:09 pm

TPET

Trio Petroleum Corp. (NYSE:TPET) has secured a four-month option to acquire a natural gas prospect in the Sacramento Basin, California. The prospect has the potential to produce an estimated 40 billion cubic feet of gas and is fully leased with permitting for an exploration well in an advanced stage. The company believes this acquisition could provide significant natural gas production and cash flow, diversifying its assets and ensuring its growth.

Portfolio Pulse from Happy Mohamed

October 23, 2023 | 12:07 pm